Where Scientific
Rigor Meets
Operational Speed.

FFC deploys biotech-grade standards — GMP, EU-GMP, FDA frameworks, and molecular diagnostics expertise — into sectors that have historically operated without them. The result: measurable advantages in compliance, quality, yield, and market positioning.

Inquire Now

What We Offer.

Our profile uniquely integrates:

  • Deep scientific expertise (PhD + diagnostics R&D)

  • Operational leadership (facility-scale execution)

  • Capital markets + M&A experience

  • Global regulatory and market entry strategy

This combination positions us as a hybrid operator–scientist–strategist specialized in a wide range of services, sectors and settings.

Services

    • Led and contributed to competitive cannabis license applications (<5% odds): 2 Utah dispensary licenses awarded; Illinois craft cultivation license was awarded, with successful exit; New Jersey Cultivation and Manufacturing licenses; multiple Massachusetts licenses awarded (4 retail, 1 cultivation, 1 manufacturing); Alabama (2 manufacturing licenses awarded to different clients, each <5% odds of winning)

    • Deep expertise in DPH/CCC regulatory frameworks, testing protocols, and compliance

    • Developed GMP/QMS systems, SOPs, and ISO-aligned processes across multiple facilities

    • Experience with FDA (510k), cGLP, QSR, ISO 13485, CLIA in molecular diagnostics

    • Oversaw regulatory inspections and compliance in cultivation and production environments

    • Led due diligence for $MM acquisitions of vertically integrated cannabis companies, typically performing extensive on-site due diligence, assisting to streamline and improve operations before and after M&A, restructuring companies, performing extensive risk analysis, value appraisal and asset evaluation

    • Experience in investment banking and financial advisory at Hercules Capital Group (business plans, investor pitch decks, proformas/financial modeling)

    • Built offering memorandums, valuation models, and capital sourcing strategies

    • Supported equity/debt financing transactions up to $500M

    Advised on corporate restructuring and bridge financing

    • Led due diligence for $MM acquisitions of vertically integrated cannabis companies, typically performing extensive on-site due diligence, assisting to streamline and improve operations before and after M&A, restructuring companies, performing extensive risk analysis, value appraisal and asset evaluation

    • Directed end-to-end cultivation, extraction, and production operations (16K ft² facility)

    • Oversaw launch of vertically integrated operations for a new facility, launching cultivation, processing and retail; oversaw hiring, training, ERP identification and integration 

    • Established inventory systems, supply chain processes, and automation frameworks

    Led facility design, A&E planning, and process engineering (20K–100K+ ft² operations)

    • R&D Lead for a $25M IVD platform (QPCR-based diagnostics)

    • Developed assays and validation protocols (LoD, analytical reactivity, stability, etc.)

    • Experience across infectious disease, oncology, and genetic diagnostics

    • Advanced expertise in PCR/QPCR, bioinformatics, and biomarker development

    Contributed to next-generation imaging diagnostics (MRI-based platforms)

    • Scientific advisor to multiple companies on:

      • Cannabinoid formulations and drug delivery systems

      • Testing methodologies (HPLC, GC-MS, QPCR)

      • Genomics, plant cell culture, and IP development

    • Advisor on EU-GMP/GACP compliance and digital horticulture platforms

    • Led research design (e.g., pesticide pyrolysis studies)

    20+ years of academic and translational research leadership

    • Supported multi-state and international cannabis market entry (US + Canada)

    • Guided early-stage companies (CEO role at Evokanna) through licensing and positioning

    • Developed go-to-market strategies for nutraceutical and cannabis products

    • Advised on international expansion and compliance alignment (EU-GMP readiness)

    Experience in emerging markets and cross-border commercialization strategy

  • Insurance claims and regulatory issues

Sectors

Settings

    • Direct operational and consulting experience across:

      • MA, NJ, MD, CA, UT, and others

    • Nationwide exposure to state-by-state regulatory frameworks

    • Advisory roles for:

      • Licensed producers (e.g., Cape Breton project)

      • Cannabis operations and compliance systems

    • Experience with Health Canada-aligned standards (GPP/GMP)

    • Experience aligning operations to EU-GMP and GACP standards

    • Advisory on export readiness and compliance frameworks

    • Indirect exposure via:

      • Capital markets and international consulting engagements

      • Emerging market strategy through advisory roles

    • Exposure through:

      • Investment and project evaluation (renewable energy, biotech)

      • Early-stage/emerging market advisory contexts

    • Exposure via:

      • Scientific collaborations and global research ecosystem

      • Capital markets and international project work

    • Development of cannabis-derived nutraceutical products

    • Achieved regulatory approvals (e.g., CDPH dosing qualification)

    Advisory on formulation, delivery systems, and compliance

    • Leadership in molecular diagnostics (IVD platform development)

    • Academic and industry experience in:

      • Molecular biology

      • Bioinformatics

      • Imaging diagnostics

    Experience with clinical lab standards (CLIA, FDA, ISO)

    • Experience with IVD systems and diagnostic platforms

    • Familiarity with regulated device environments (FDA 510k, ISO 13485)

    Development of hardware-integrated diagnostic workflows

    • Extensive experience across:

      • Cultivation (indoor + greenhouse)

    Extraction (CO₂ systems, Hydrocarbon extraction, Ethanol extraction, solventless extraction, distillation)

    • Manufacturing (edibles, MIPs)

    • Testing labs and QC systems

    • Facility scale: 16K–100K+ ft² operations

    Expertise in seed-to-sale systems, IPM, fertigation, environmental controls

The FFC Approach.

Speed

Together, we outline a path forward that’s realistic, strategic, and tailored to your specific needs.

Small. Expert. Unrestricted by bureaucracy. Every engagement is led by our team of experts.

Scientific Depth

PhD-level rigor applied where most consulting firms send generalists.

Direct Accountability

You work with Dr. Hoffman. Not a team that reports to him.

Global Reach

Active in the Americas, Europe, and Africa since 2017.

Past Project.

  • We came to Matthew knowing the odds were brutal — under 5% in a state where every application had to be flawless. What set FFC apart wasn't just the science; it was the way Dr. Hoffman built a complete narrative around our operations, compliance model, and patient access strategy. He coordinated everything — legal, architectural, financial — and made it cohere into something that actually told a story to regulators. We walked away with both licenses in Salt Lake City and St. George. That doesn't happen without someone who genuinely understands both the regulatory environment and the human side of what these commissions are evaluating.

    Rich Silverstein
    Justice Grown

  • Matthew came in when we had a facility and a vision but no operational infrastructure. By the time he was done, we had 180+ SOPs, a fully trained team, integrated ERP systems, and a cultivation program that hit 65 g/SF on our first harvest with zero testing failures. We passed our CCC Pre-Licensure Inspection with a perfect score and won first place at NECANN within nine months of launch. I've worked with a lot of consultants. Matthew is one of the rare ones who actually gets his hands in it — he's not writing memos from a distance, he's building something real alongside you.

    Jason Bates
    Aura Cannabis Company

  • We needed someone who could walk into a vertically integrated operation and give us an honest, rigorous picture — not a polished pitch deck. Dr. Hoffman conducted on-site audits across cultivation, extraction, and retail, evaluated our COGs and yield efficiency, identified compliance gaps we hadn't even flagged internally, and handed us a post-close integration roadmap that was immediately actionable. The acquisition went through successfully, and the visibility we had going in — because of Matthew's work — meant we weren't discovering problems after the fact. That's exactly what you need in a transaction like this.

    Jack Hudson
    Founder & CEO of Ermont Inc.

Ready to move? Let’s Work Together.

FFC takes on select engagements. If your project requires direct expert involvement in compliance, capital, or operations — reach out.